Initial Public Offering

Healthcare
Initial Public Offering

Summary

Baird served as a co-manager on this offering

About

InMode Ltd. (“InMode” or the “Company”) (NASDAQ-GS: INMD) recently completed an initial public offering of 5,500,000 shares of common stock (including exercise of the overallotment option) at a price of $14.00 per share, generating gross proceeds of $77.0 million. The Company intends to use the net proceeds from the offering to expand sales and marketing operations, continue research and development, fund strategic acquisitions and for general corporate purposes.

InMode is a leading global provider of innovative medical technologies that develops, manufactures and markets devices harnessing novel radio-frequency (RF) technology. The Company strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically-accepted minimally-invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology and ophthalmology. The Company is based in Lake Forest, California, and Yokneam, Israel.
CONTACT US TO LEARN MORE
Healthcare
Initial Public Offering
Date
August 2019
Company
InMode Ltd.
Transaction
M&A
Sectors
Healthcare
Target Location
North America

Share